Re-Assessing PK/PD Issues for Oral Protein and Peptide Delivery
Due to a lack of safe and effective oral delivery strategies for most protein and peptide therapeutics, pharmaceutical drug developers have focused on parenteral routes to administer these agents. Recent advances in delivery technologies have now shown clinical validation for a few of these biopharm...
| Published in: | Pharmaceutics |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-07-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/13/7/1006 |